Pentax, Takeda & more — 6 GI company key notes

Here are six updates on GI companies from the past week:

Advertisement

Pentax Medical acquired a controlling interest in PlasmaBiotics SAS, an endoscope drying and storage device manufacturer.

Takeda completed its squeeze-out of TiGenix, acquiring complete control of the company.

Takeda entered into an agreement with HiFiBiO to research antibody therapies to treat gastrointestinal diseases, cancer and other disorders.

To expand its presence in the endoscopy market, Fujifilm Medical Systems U.S.A. launched its new 700 Series Endoscopes, growing its Eluxeo platform.

The Japanese Patent Office issued Motus GI a patent for its Pure-Vu colonoscopy preparation system.

A new test from Rhythm Biosciences has the potential to detect a type of colon polyp often missed by colonoscopies.

More articles on GI and endoscopy:
What’s important to patients post-colorectal surgery? 3 study insights
This low-cost solution improved ADRs for GIs: 6 important research findings
These 25 states have CRC control programs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.